Intrathecal Pain Pump: Benefits, Risks, and Who Is a Good Candidate

When chronic pain no longer responds to oral medications, physical therapy, or injections, many patients and their doctors start exploring more targeted options. An intrathecal pain pump is one of the most effective tools available for long-term pain relief, but it is not the right choice for everyone.

This guide covers what intrathecal pain pumps do, what patients can realistically expect from the therapy, and the specific criteria that help physicians identify strong candidates. If you are wondering whether this treatment might be appropriate for you, the information below will help you ask the right questions before your next appointment.

What Is an Intrathecal Pain Pump?

An intrathecal pain pump (also called an intrathecal drug delivery system) is a small, surgically implanted device that delivers pain medication directly into the fluid surrounding your spinal cord. The pump sits beneath the skin of your abdomen, and a thin catheter routes medication from the pump to the intrathecal space in your spine.

Because medication reaches the spinal cord directly rather than traveling through the digestive system and bloodstream, the doses required are dramatically smaller. Patients typically receive about 1/300th of the oral equivalent dose needed to achieve the same level of pain control. That difference in dosage is one of the primary reasons physicians consider this therapy when oral medications are causing significant side effects or losing effectiveness.

At Kentuckiana Pain Specialists, Dr. Ajith Nair has performed hundreds of intrathecal pain pump implantations over more than 20 years. The practice is recognized as one of the largest pain pump implanting centers in the Louisville region.

How Does an Intrathecal Pain Pump Work?

The device holds a reservoir of medication (typically morphine, hydromorphone, ziconotide, or baclofen) that is slowly released through a programmable pump mechanism. The pump can be pre-programmed by your physician to release medication at specific intervals and doses, or in some cases adjusted by the patient using a small remote.

Refills are handled during routine office visits every one to three months, depending on your dosage and the size of your pump reservoir. During these appointments, Dr. Nair also checks pump function and adjusts your programming as needed.

The pump itself typically lasts five to seven years before the battery requires replacement. The catheter, if properly placed and maintained, can remain functional much longer.

Benefits of Intrathecal Pain Pump Therapy

For patients who meet the criteria, intrathecal therapy offers several meaningful advantages over systemic pain management approaches.

Dramatically lower medication doses

Because medication is delivered at the site of action, patients can achieve equivalent or better pain relief at a fraction of the dose required orally. This reduction in systemic exposure lowers the risk of side effects that often accompany high-dose oral opioids, including cognitive fog, constipation, hormonal changes, and respiratory depression.

Consistent, controlled delivery

The pump maintains a steady, programmable flow of medication rather than the peaks and valleys that come with oral dosing schedules. Many patients report that this consistency improves their ability to function during daily activities and sleep.

Potential for significant pain reduction

In appropriately selected patients, intrathecal therapy has been shown to reduce pain scores by 50 to 90 percent. Functional improvements, including return to work and resumption of activities that had been limited by pain, are frequently documented in the clinical literature and in outcomes at our practice.

Reduced dependence on oral opioids

For patients who have been escalating oral opioid doses to manage uncontrolled pain, a pain pump can significantly reduce or eliminate the need for systemic opioid medications. This aligns with a broader clinical goal of minimizing the risks associated with long-term high-dose opioid therapy.

Adjustability over time

Unlike surgery that permanently alters anatomy, the pump can be reprogrammed non-invasively as your pain needs change. If a medication stops working as well, your physician can modify the dosing schedule or switch to a different drug without requiring a new procedure.

Reversibility

If the therapy is not working or a patient’s condition changes, the pump can be surgically removed. While removal is a procedure, the underlying anatomy is not permanently altered the way it would be with a spinal fusion or nerve ablation.

Risks and Side Effects to Know

Intrathecal therapy is an advanced intervention that carries risks both from the surgery itself and from the ongoing use of the device. A thorough conversation with your physician about these risks is a required part of the evaluation process.

Surgical and procedural risks

As with any implant procedure, there is a small risk of infection at the surgical site or along the catheter track. Bleeding, spinal fluid leak (which can cause headaches), and anesthesia reactions are also possible complications. The procedure is performed in an ambulatory surgery center under general anesthesia, and the medical team monitors for these issues throughout recovery.

Device-related complications

The catheter can occasionally kink, migrate, or become blocked, which may lead to reduced medication delivery or, in rare cases, a sudden drop in medication that requires prompt medical attention. The pump itself can malfunction, and the battery will eventually require replacement surgery.

Medication-related side effects

Even at lower doses, intrathecal medications can still cause side effects including nausea, drowsiness, urinary retention, or respiratory changes. Ziconotide, a non-opioid option sometimes used in intrathecal pumps, carries its own specific profile of neurological side effects that requires close monitoring, particularly during the initiation phase.

Dependency and withdrawal considerations

If the pump malfunctions or is removed suddenly, patients on opioid-based therapy can experience withdrawal symptoms. This is why proper programming, regular follow-up, and a clear emergency plan are standard parts of ongoing care.

Activity restrictions

Patients with implanted pumps must avoid certain high-impact activities, MRI protocols may need modification (though many modern devices are MRI-conditional), and air travel or significant altitude changes can occasionally affect the device. Your physician will review these considerations in detail before implantation.

Who Is a Good Candidate for an Intrathecal Pain Pump?

Patient selection is the most important factor in determining whether intrathecal therapy will be successful. The criteria used by pain specialists reflect decades of clinical research on which patients tend to benefit most.

You have chronic, severe pain that has not responded to conservative treatment

Candidates typically have documented chronic pain, often lasting six months or longer, that has not adequately responded to a reasonable trial of conservative therapies. This includes physical therapy, oral medications, nerve blocks, and other interventional procedures. If pain is still manageable with less invasive approaches, those options should generally be exhausted first.

You have a diagnosis that responds to intrathecal therapy

The conditions most commonly treated with intrathecal pumps include:

• Failed back surgery syndrome (persistent pain after spinal surgery)
• Cancer pain that is difficult to manage with systemic medications
• Complex regional pain syndrome (CRPS)
• Neuropathic pain from spinal cord injury
• Chronic pancreatitis pain
• Muscle spasticity related to multiple sclerosis, cerebral palsy, or spinal cord injury
• Refractory chronic migraines

You are experiencing significant side effects from oral opioids

If you are currently managing chronic pain with oral opioids but experiencing intolerable side effects, cognitive impairment, or declining quality of life from the medication rather than just the pain itself, intrathecal delivery may offer a way to preserve pain control while dramatically reducing systemic drug exposure.

You passed a psychological evaluation

Before permanent implantation, candidates undergo a psychological screening. This evaluation looks at factors including realistic expectations, the absence of untreated psychiatric conditions that might interfere with outcomes, substance use history, and overall readiness for device-based therapy. This step protects patients from choosing a major intervention when the primary drivers of suffering are psychological rather than physical.

You had a positive response during the trial phase

Before any permanent implant is performed, patients undergo a trial with temporary intrathecal medication delivery. The standard threshold for a positive trial is a reduction in pain scores of 50 percent or more. Patients who do not achieve this level of relief during the trial are not good candidates for permanent implantation.

You are medically stable enough for surgery

Because implantation requires general anesthesia and a minor surgical procedure, candidates need to be medically cleared. Uncontrolled bleeding disorders, active infections, or other acute medical conditions may need to be addressed before proceeding.

Who Is NOT a Good Candidate?

There are clinical situations where intrathecal therapy is unlikely to be appropriate, at least not without addressing other issues first.

• Active systemic infection: Implanting a device when an infection is present significantly increases the risk of device-related infection.
• Untreated coagulopathy or bleeding disorder: Impaired clotting increases the risk of surgical bleeding or spinal hematoma.
• Unresolved psychological factors: Significant untreated depression, anxiety, or active substance use disorder can reduce outcomes and should be addressed alongside or before proceeding with device therapy.
• A primary pain source that is surgically correctable: If there is a structural problem that a surgeon can fix (such as a herniated disc compressing a nerve), that option should typically be explored first before considering a pain management device.
• Failure to respond during the trial: A trial that does not produce at least 50 percent pain reduction is a strong signal that permanent implantation is unlikely to be beneficial.
• Inability to manage ongoing device care: Patients must be able to attend regular refill appointments and maintain follow-up care. Those unable to commit to this schedule may not be appropriate candidates for this type of therapy.

What to Expect: The Trial and Implantation Process

The path to a permanent pain pump involves two distinct phases.

Phase 1: The Trial

The trial phase involves temporary delivery of intrathecal medication, usually through a catheter placed in the office or a procedure room. Over several days, you and your care team monitor your pain levels, side effects, and functional status. If you achieve at least 50 percent pain reduction and tolerate the medication well, you are considered a strong candidate for permanent implantation.

Phase 2: Permanent Implantation

The implant surgery is a two-part procedure performed under general anesthesia at an ambulatory surgery center:

1. A thin catheter is threaded into the intrathecal space through a small incision in the lower back.
2. The pump device is placed in a pocket created just below the waistline, typically on the side of the abdomen.

Most patients are discharged the same day. Dr. Nair programs the pump’s initial settings before discharge, and a follow-up appointment is scheduled within the first week to check the incision and confirm proper device function.

Life With a Pain Pump: Ongoing Care

Managing a pain pump is an ongoing partnership between patient and physician. Every one to three months, you will return to the office for a medication refill. During these visits, Dr. Nair checks the pump’s function, reviews your pain levels and any side effects, and adjusts programming as needed.

Most patients find that pump management becomes a predictable, low-burden part of their routine. The refill visit typically takes less than an hour, and the non-invasive programming adjustments allow for fine-tuning without any recovery time.

Patients are encouraged to keep a simple pain diary between appointments, noting any changes in pain control, new symptoms, or questions for their physician. This information helps guide programming decisions and ensures that therapy stays aligned with your changing needs.

Frequently Asked Questions

How long does it take to feel relief after a pain pump is implanted?

Many patients notice a meaningful reduction in pain within days of implantation. However, full optimization can take several months as Dr. Nair adjusts the programming based on your response. The trial phase gives you a preview of how quickly your body responds to intrathecal medication.

Can I still take oral pain medications after getting a pain pump?

In many cases, intrathecal therapy reduces the need for oral pain medications substantially or eliminates it. However, the transition is gradual and supervised. Your physician will guide you through any changes to your oral medication regimen based on how your pain responds.

What happens if the pump runs out of medication?

Running out of medication before a scheduled refill is preventable with consistent follow-up appointments. Your pump holds enough medication to last well between visits, and the pump tracks reservoir volume. If you notice a sudden return of pain or other symptoms, contact your physician right away.

Is the procedure covered by insurance?

Intrathecal pain pump therapy is covered by most major insurance plans, including Medicare and Medicaid, when medical necessity criteria are met. Kentuckiana Pain Specialists accepts 17 major insurance carriers and provides pre-treatment authorization support at no additional charge.

Who is not a candidate for an intrathecal pain pump?

Patients with active infections, uncontrolled bleeding disorders, certain untreated mental health conditions, or those who did not respond positively during the trial phase are generally not appropriate candidates. A thorough evaluation will identify whether other therapies should be pursued first.

Is an Intrathecal Pain Pump Right for You?

Intrathecal pain pump therapy is not a first-line treatment. It is a carefully considered option for patients with chronic, severe pain that has not been adequately controlled through less invasive means. When patient selection is done well, the results can be significant: better pain control, fewer medication side effects, and a meaningful improvement in quality of life.

If you are currently managing chronic pain with high doses of oral medications, or if conservative treatments have not given you the relief you need, a consultation with a pain management specialist is the right next step.

If you already have a pain pump and are thinking ahead, read our guide on what to expect during pain pump removal to understand when and how the device can be removed.

Schedule a consultation with Dr. Nair at Kentuckiana Pain Specialists to discuss whether intrathecal pain pump therapy might be appropriate for your condition. With locations in Louisville and Elizabethtown, our team is ready to help you evaluate all your options and develop a treatment plan built around your specific needs.